Quality assurance of axillary radiotherapy in the EORTC AMAROS trial 10981/22023: the dummy run

被引:53
作者
Hurkmans, CW
Borger, JH
Rutgers, EJT
van Tienhoven, G
机构
[1] Catharina Hosp, Dept Radiotherapy, NL-5602 ZA Eindhoven, Netherlands
[2] RTIL, Dept Radiotherapy, NL-6401 CX Heerlen, Netherlands
[3] NKI Avl, Dept Surg, NL-1066 CX Amsterdam, Netherlands
[4] AMC, Dept Radiotherapy, NL-1105 AZ Amsterdam, Netherlands
关键词
breast cancer; axillary radiotherapy; randomised trial; quality assurance;
D O I
10.1016/S0167-8140(03)00194-4
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: To assess and if needed improve the compliance of participating institutions to the radiotherapy guidelines of the EORTC AMAROS trial 10981/22023 comparing axillary radiotherapy to axillary surgery in sentinel node positive patients with early stage breast cancer. Materials and methods: A transverse contour and a frontal view radiograph of the axillary region of a 'dummy' patient were sent to all institutions intending to participate in the trial with the request to produce a radiotherapy treatment plan according to the protocol guidelines. Additional information on dose prescription, the treatment technique and field matching with breast fields and internal mammary lymph node fields was requested in a questionnaire. Results: Eighteen institutions have performed the dummy run. At first assessment, the dose was not specified according to the protocol in seven cases, while two institutions did not comply with the dose prescription of 50 Gy in 25 fractions. Dose heterogeneity was over 20% in 10 institutions, caused by the use of a two-field technique in eight cases. Ten institutions did not apply special techniques to obtain non-overlapping match planes. In 10 cases, one or more field borders or blocks were positioned incorrectly. Following recommendations from the quality assurance committee given to the participating institutions on an individual basis, 10 institutions adapted their technique. Thereafter, 16 institutions could be accepted for trial participation. Conclusions: A number of potential protocol deviations were found at first assessment. Since recommendations led to a large number of adaptations by the participants, a considerable improvement in protocol compliance and inter-institutional consistency was achieved. (C) 2003 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:233 / 240
页数:8
相关论文
共 31 条
[1]   Evaluation of level I and II axillary nodes included in the standard breast tangential fields and calculation of the administered dose: Results of a prospective study [J].
Aristei, C ;
Chionne, F ;
Marsella, AR ;
Alessandro, M ;
Rulli, A ;
Lemmi, A ;
Perrucci, E ;
Latini, P .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2001, 51 (01) :69-73
[2]   Variability of the depth of supraclavicular and axillary lymph nodes in patients with breast cancer: Is a posterior axillary boost field necessary? [J].
Bentel, GC ;
Marks, LB ;
Hardenbergh, PH ;
Prosnitz, LR .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2000, 47 (03) :755-758
[3]   Clinical impact of dosimetry quality assurance programmes assessed by radiobiological modelling of data from the thermoluminescent dosimetry study of the European Organization for Research and Treatment of Cancer [J].
Bentzen, SM ;
Bernier, J ;
Davis, JB ;
Horiot, JC ;
Garavaglia, G ;
Chavaudra, J ;
Johansson, KA ;
Bolla, M .
EUROPEAN JOURNAL OF CANCER, 2000, 36 (05) :615-620
[4]  
BRUCE J, 1971, CANCER, V28, P1443, DOI 10.1002/1097-0142(197112)28:6<1443::AID-CNCR2820280617>3.0.CO
[5]  
2-T
[6]  
CATALIOTTI L, 2001, MAPPING AXILLA RADIO
[7]   Quality assurance of the EORTC trial 22911. A phase III study of post-operative external radiotherapy in pathological stage T3NO prostatic carcinoma: the dummy run [J].
Davis, JB ;
Reiner, B ;
Dusserre, A ;
Giraud, JY ;
Bolla, M .
RADIOTHERAPY AND ONCOLOGY, 2002, 64 (01) :65-73
[8]   QUALITY ASSURANCE OF THE EORTC RADIOTHERAPY TRIAL-22863 FOR PROSTATIC-CANCER - THE DUMMY RUN [J].
DUSSERRE, A ;
GARAVAGLIA, G ;
GIRAUD, JY ;
BOLLA, M .
RADIOTHERAPY AND ONCOLOGY, 1995, 36 (03) :229-234
[9]   REANALYSIS AND RESULTS AFTER 12 YEARS OF FOLLOW-UP IN A RANDOMIZED CLINICAL-TRIAL COMPARING TOTAL MASTECTOMY WITH LUMPECTOMY WITH OR WITHOUT IRRADIATION IN THE TREATMENT OF BREAST-CANCER [J].
FISHER, B ;
ANDERSON, S ;
REDMOND, CK ;
WOLMARK, N ;
WICKERHAM, DL ;
CRONIN, WM .
NEW ENGLAND JOURNAL OF MEDICINE, 1995, 333 (22) :1456-1461
[10]   10-YEAR RESULTS OF A RANDOMIZED CLINICAL-TRIAL COMPARING RADICAL MASTECTOMY AND TOTAL MASTECTOMY WITH OR WITHOUT RADIATION [J].
FISHER, B ;
REDMOND, C ;
FISHER, ER ;
BAUER, M ;
WOLMARK, N ;
WICKERHAM, DL ;
DEUTSCH, M ;
MONTAGUE, E ;
MARGOLESE, R ;
FOSTER, R .
NEW ENGLAND JOURNAL OF MEDICINE, 1985, 312 (11) :674-681